Medinotec Inc.
MDNC
$5.00
$0.000.00%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 79.40% | 70.46% | 56.62% | 28.09% | 414.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 79.40% | 70.46% | 56.62% | 28.09% | 414.25% |
| Cost of Revenue | 27.15% | 85.50% | -11.02% | 33.87% | 1,491.15% |
| Gross Profit | 140.24% | 54.14% | 145.76% | 20.48% | 187.58% |
| SG&A Expenses | 272.02% | 98.32% | -41.47% | -28.21% | 79.36% |
| Depreciation & Amortization | -61.54% | -58.10% | -37.45% | 65.52% | 57.26% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 97.89% | 88.93% | -21.89% | 16.79% | 363.67% |
| Operating Income | 21.32% | 3.08% | 696.06% | 104.54% | 682.23% |
| Income Before Tax | 32.54% | 22.75% | 928.61% | 212.16% | 1,377.60% |
| Income Tax Expenses | 58.19% | 17.42% | 404.86% | 171.75% | 8,492.86% |
| Earnings from Continuing Operations | 21.74% | 30.50% | 1,398.17% | 163.02% | 957.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.74% | 30.50% | 1,398.17% | 163.02% | 957.53% |
| EBIT | 21.32% | 3.08% | 696.06% | 104.54% | 682.23% |
| EBITDA | 16.27% | -2.53% | 600.82% | 100.62% | 520.59% |
| EPS Basic | 50.00% | 31.08% | 976.64% | 175.00% | 814.29% |
| Normalized Basic EPS | 57.61% | 15.70% | 575.00% | 193.14% | 1,182.35% |
| EPS Diluted | 50.00% | 31.08% | 976.64% | 175.00% | 814.29% |
| Normalized Diluted EPS | 57.61% | 15.70% | 575.00% | 193.14% | 1,182.35% |
| Average Basic Shares Outstanding | -18.86% | 0.00% | 39.50% | -15.97% | 21.34% |
| Average Diluted Shares Outstanding | -18.86% | 0.00% | 39.50% | -15.97% | 21.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |